Harald Hampel (Biography – English version)

Professeur Harald Hampel, MD, PhD, MA, MSc

The AXA-UPMC chair of the Institut de la Mémoire et de la Maladie d’Alzheimer at Pierre and Marie Curie University is held by Professor Harald Hampel, an internationally recognised expert. This chair is endowed with capital of 3 million euros and has the objective of improving the diagnosis of the Alzheimer disease to prevent its effects before the symptoms appear. In particular it explores the lead of biomarkers, whose recent development has enabled researchers to study this disease in a new way and better evaluate the effectiveness of treatments.

After a post-doctoral fellowship at the National Institute of Health (Bethesda, USA), Professor Hampel became professor of psychiatry and founding director of the Alzheimer Memorial Center at Munich University before being appointed professor and chair of psychiatry at Trinity College, Dublin.

In 2010, he was appointed professor and Chair of psychiatry at the University of Frankfurt and in 2013 as professor and AXA Research Fund Chair at Pierre and Marie Curie University, Départment de Neurologie, Institut de la Mémoire et de la Maladie d’Alzheimer (Hôpital de la Salpêtrière, Paris).

Here are the main topics of Professor Harald Hampel’s research:

  • Investigating the asymptomatic stage of the Alzheimer’s disease
  • Identifying new biomarkers to facilitate an early diagnosis
  • Developing easier and less invasive tests
  • Anticipating the disease in high-risk populations
  • Enabling the testing of early-administrated personalised treatments

His objective is to develop a precision medicine, or 4P medicine (Predictive, Preventive, Personalised and Participatory), for neurodegenerative diseases. This evolution of current medicine to future medicine has been made possible by the arrival of new tools (computer science, big data…).

Professor Harald Hampel has published more than 500 peer-reviewed research papers and edited 8 books, won multiple awards for his research focusing on brain health & disease, biomarker and therapy discovery in Alzheimer’s disease. He holds international research grants and is principal investigator of research consortia. In addition is senior Associate Editor of the journal of the Alzheimer Association, Alzheimer’s & Dementia.

Version française